SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus (Q38084363)

28 August 2017

title

SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus (English)

1 reference

28 August 2017

author name string

Aaishwarya B Deshmukh

series ordinal

1 reference

28 August 2017

Maharshi C Patel

series ordinal

1 reference

28 August 2017

Bharat Mishra

series ordinal

1 reference

28 August 2017

publication date

25 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

566-572

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Defining and characterizing the progression of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Anatomical and developmental patterns of facilitative glucose transporter gene expression in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Sodium-glucose transporter-2 inhibition as an antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

21 January 2018

Learning From Glycosuria

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Expression cloning and cDNA sequencing of the Na+/glucose co-transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

A glucose sensor hiding in a family of transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

HNF1alpha controls renal glucose reabsorption in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Effect of diabetes and insulin of the maximum capacity of the renal tubules to reabsorb glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Nutrition in patients with Type 2 diabetes: are low-carbohydrate diets effective, safe or desirable?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Risk factors for symptomatic urinary tract infection in women with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

Beneficial effect of T-1095, a selective inhibitor of renal Na+-glucose cotransporters, on metabolic index and insulin secretion in spontaneously diabetic GK rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2013.766560

10.3109/0886022X.2013.766560

21 January 2018

Identifiers

DOI

1 reference

release_mafadzcoqfdzdfgxxk5lashnui

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mafadzcoqfdzdfgxxk5lashnui

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference